AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 58 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,313,000 | -82.2% | 280,665 | -64.9% | 0.02% | -79.6% |
| Q2 2015 | $13,000,000 | +12.7% | 800,499 | +181.1% | 0.09% | +12.0% |
| Q1 2015 | $11,537,000 | -58.8% | 284,733 | -45.1% | 0.08% | -59.7% |
| Q4 2014 | $28,025,000 | +107.0% | 518,982 | +31.1% | 0.21% | +89.0% |
| Q3 2014 | $13,537,000 | – | 395,947 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,382,735 | $22,455,000 | 6.33% |
| Wildcat Capital Management, LLC | 235,264 | $3,821,000 | 1.31% |
| Ghost Tree Capital, LLC | 150,000 | $2,436,000 | 0.79% |
| Redmile Group, LLC | 537,282 | $8,725,000 | 0.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,008,337 | $16,375,000 | 0.48% |
| Green Owl Capital Management, LLC | 35,000 | $568,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 154,006 | $2,501,000 | 0.30% |
| MARINER INVESTMENT GROUP LLC | 69,000 | $1,121,000 | 0.29% |
| DSC Advisors, L.P. | 26,129 | $424,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 197,800 | $3,212,000 | 0.12% |